Foster, P.
Genentech
2 papers on CoChatORCID 0009-0008-3268-5426
Most cited papers
- Verified
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.
Hellmann, M. D., Kim, T.-W., Lee, C. B., Goh, B.-C., Miller, W. H., Oh, D.-Y., Jamal, R., Chee, C.-E., Chow, L. Q. M., Gainor, J. F., et al. (2019) · Annals of Oncology
Cancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways
Cited by 174
- Verified
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models
Foster, P., Yamaguchi, K., Hsu, P. P., Qian, F., Du, X., Wu, J., Won, K.-A., Yu, P., Jaeger, C. T., Zhang, W., et al. (2015) · Molecular Cancer Therapeutics
PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and Cancer
Cited by 58
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free